About Celldrop

Revolutionizing Healthcare with Next Generation Stem Cell Therapies; First in Animals, then in Humans.

CellDrop Biosciences is a cell therapy biotech that has developed a novel method to improve cellular medicines. Our first product is a mesenchymal stem cell (MSC) therapy to improve healing speed and durability in Equine tendon and ligament injuries.

Our Technology

More Effective Cell Therapies with Off-The-Shelf Convenience

We have improved upon traditional cell therapies by encapsulating living therapeutic cells in inert injectable microparticles. Our patent pending Tri-Phasic encapsulation process produces encapsulated cells with greater than 90% viability.

The technology enables 2 key things:

  • The safe use of Allogeneic cells by preventing host immune detection
  • Improved healing by keeping injected cells alive and localized at an injury site.
Technology

Our Vision

Mass producible living therapies, for everyone

The founding vision of CellDrop was to create readily available healing solutions that go beyond mere treatment. We have delivered on this by developing truly high viability cell encapsulation that enables the creation of scalable, off the shelf cell therapies.

How we got here

Developed our tri-phasic encapsulation process to enable high viability cell encapsulation at commercial scales.

Targated the prevalent and costly problem of superficial digital flexor tendon and suspensory ligament injuries in performance horses.

Created an off-the-shelf allogeneic MSC therapy targeted for this indication.

Where we're going

Bringing our flagship MSC therapy to the equine veterinary market.

Adding additional indications for arthritis in companion animals.

Using the extensive animal trial data and veterinary product cash flow to efficiently translate our product to human orthopedics with an initial indication for osteoarthritis.

Creating a paradigm shift towards living therapies in medicine

Our Platform in a nutshell

Our platform has been used with dozens of cell types, and our first commercial product will be an encapsulated Mesenchymal Stem Cell (MSC) therapy for equine tendon and ligament injuries.We are developing additional off the shelf MSC products for arthritis in dogs, cats, and humans.

investor info
Driven by Expertise, Innovation, and a Passion for Optimized Health

The breakthroughs and innovations at CellDrop Biosciences happen because of the dedication and expertise of our team. Meet the folks who make the magic happen.

The celldrop team